The European dermatology and cosmetics M&A market continues to show a strong growth trajectory. In 2025, a total of 116 corporate transactions were recorded across Europe, compared with 90 in 2021, representing an increase of nearly 30%, according to the Dermatology and Cosmetics M&A Report prepared by Albia IMAP.
This trend confirms the investment appeal of a sector that combines structural growth, resilience, and high barriers to entry. While global M&A activity has moderated since the peaks reached in 2021, dermatology and cosmetics have continued to attract the interest of both strategic buyers and financial investors, consolidating their position as one of the most dynamic segments within the consumer and healthcare industries.
According to data analyzed by Albia IMAP, Spain has also strengthened its role within the European market. The number of transactions increased from 13 deals in 2021 to 22 in 2025, representing growth of 69% in just four years. This progress places the Spanish market among the most active in Europe and reflects the growing interest in domestic companies specializing in dermatology, dermopharmacy, cosmetics, fragrances, and personal care.
Fernando Cabos, Partner at Albia IMAP, commented: “Dermatology and cosmetics have established themselves as one of the most attractive sectors for corporate investment. The combination of sustained growth, innovation capabilities, brand strength, and consolidation opportunities is driving intense M&A activity. Furthermore, the increasing sophistication of the sector from a scientific, commercial, and regulatory perspective favors companies with greater scale and differentiated capabilities, making acquisitions a key tool for accelerating growth and enhancing competitiveness.”
The role of strategic buyers remains particularly significant in Spain. During 2025, 59% of transactions were led by companies operating within the sector, while private equity funds accounted for the remaining 41%. This distribution highlights how companies are increasingly turning to inorganic growth strategies to expand their product portfolios, acquire technological and scientific capabilities, strengthen their position in high-value-added segments, and accelerate international expansion.
The market’s dynamism is also supported by the industry’s strong growth prospects. Rising demand linked to wellness, personal care, and skin health, together with the convergence of cosmetics, dermatology, consumer health, and technology, is creating new opportunities for strategic operators and investors. In a market that remains fragmented and offers significant economies of scale, corporate transactions continue to establish themselves as one of the main drivers of transformation and growth for the sector across Europe.
Albia IMAP
Albia IMAP is a leading Spanish advisory firm specializing in mergers and acquisitions (M&A), financing, and corporate development for middle-market companies.
With offices in Madrid, Barcelona, and Bilbao, Albia IMAP provides nationwide coverage and is part of IMAP, one of the world’s leading international M&A advisory organizations, ranked among the global Top 10, with a presence in more than 50 countries, over 70 offices, and nearly 500 professionals.
The firm has more than 20 years of experience and a track record of over 200 transactions in Spain, representing an aggregate deal value of approximately €3 billion. Albia IMAP also maintains a strong international focus, with around 50% of its activity involving cross-border transactions. In 2025, the firm further strengthened its market position by successfully completing 14 transactions.
Request the full report here:
https://albiacapital.com/informe/informe-de-ma-dermatologia-y-cosmetica-abril-2026/
cloud technology axon
Since January 2026, CDTI Innovación, through Innvierte, has closed co...
